Services Database Community Pharmacy Take Home Naloxone

This sets out a Service Specification for Community Pharmacy Take Home Naloxone (THN).
Pharmacies are well placed to be able to provide THN and other relevant information on harm reduction as
part of the local harm reduction strategy to prevent drug related deaths. They can also signpost to other
relevant substance misuse services and facilitate increases in the number of people who have access to
THN by Pharmacies working both in partnership with Humankind and as a standalone service where
appropriate.
People employed or engaged in the provision of drug treatment services including community pharmacy staff
can supply THN that has been obtained by their pharmacy to others for the purpose of being available to
save life in an emergency. Authorisation to supply using this service only allows supplies to be made as
specified; it does not cover supplies issued on prescription or by Patient Group Direction (PGD).
This THN service relates to the supply to people aged 18 years or over for someone who is using or has
previously used opioids (illicit/prescribed) and is at potential risk of overdose, their carers, family members or
friends liable to be on hand in case of overdose. It covers the use of:
• Prenoxad® - intramuscular (given by injection into the upper arm/leg muscle) naloxone solution for
injection. The concentration is 1mg/1ml. Each pack contains 1x2ml i.e. 2mg in each prefilled syringe and
2 x 23G 1.25” needles.
• Nyxoid® - intranasal spray (sprayed into the nose) nasal spray. Each single dose container contains
1.8mg. Each pack contains two nasal sprays.